Ikonisys Future Growth

Future criteria checks 5/6

Ikonisys is forecast to grow earnings and revenue by 84.2% and 51% per annum respectively. EPS is expected to grow by 85% per annum. Return on equity is forecast to be 4.7% in 3 years.

Key information

84.2%

Earnings growth rate

85.0%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate51.0%
Future return on equity4.7%
Analyst coverage

Low

Last updated12 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:9W8 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261004N/A2
12/31/20256-12N/A2
12/31/20241-2-2N/A1
6/30/20240-3N/AN/AN/A
3/31/20240-2N/AN/AN/A
12/31/20230-2-1-1N/A
9/30/20231-2N/AN/AN/A
6/30/20231-2-2-1N/A
3/31/20231-2-2-1N/A
12/31/20221-2-2-1N/A
9/30/20221-2N/AN/AN/A
6/30/20221-1-2-2N/A
3/31/20221-1-2-1N/A
12/31/20211-1-1-1N/A
9/30/20210-1N/AN/AN/A
6/30/20210-1N/AN/AN/A
3/31/20210-1N/AN/AN/A
12/31/20200-2N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 9W8 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: 9W8 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 9W8 is expected to become profitable in the next 3 years.

Revenue vs Market: 9W8's revenue (51% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 9W8's revenue (51% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 9W8's Return on Equity is forecast to be low in 3 years time (4.7%).


Discover growth companies